About Nano Discovery

About Nano Discovery

Nano Discovery Inc. is a biotechnology company based in Orlando, Florida, United States. Nano Discovery developed, manufactures and sells single-step and washing-free immunoassay technology, D2Dx™. D2Dx™ is a platform technology that can be used for the detection and analysis of both antibody and antigen proteins. Using the conjugation kits and assay reader from Nano Discovery, any immunoassay can be customized to specific needs within hours. D2Dx™ immunoassay is simple to use with assay results obtained within 5-30 minutes. Nano Discovery’s unique technology and methodology were developed by Dr. Qun (Treen) Huo at the University of Central Florida’s Department of Chemistry and NanoScience Technology Center. Huo used a variety of UCF’s Tech Transfer programs in creating Nano Discovery Inc. at the UCF Business Incubator. The company is led by biotechnology entrepreneur and investor Davian Santana.

Our Vision

We seek to improve the lives and health of humans and animals by developing and deploying new diagnostic technologies which provide real time, actionable knowledge to combat the ever evolving threat of infectious diseases in our world. Costly pathogenic warfare, including the indiscriminate use of antibiotics, threatens not only human lives and health but also animal and plant resources that serve to support human life. Nano Discovery’s products for monitoring immune system function and activity will provide cost-effective, critical information to develop targeted solutions for the prevention, management, and control of infectious diseases.

Leadership

Davian S. Santana

Chief Executive Officer

A biotechnology entrepreneur and investor, Santana applied the knowledge and skill sets learned from his prior work in the US Navy and at various hospital laboratory systems to create his first business in 2004, Vista Clinical, which grew to be the largest privately-held clinical laboratory services provider in the Southeastern United States. While serving as President of Vista Clinical from 2004 – 2017, Santana also founded several other successful businesses – ranging from information technology to marketing – and successfully performed a number of commercial real estate transactions.

Santana brings to Nano Discovery his field expertise, business acumen, and entrepreneurial vision.

Qun Treen Huo, Ph.D.

Chief Scientific Officer

Qun Treen Huo (Ph.D.) is a co-founder of Nano Discovery Inc. and a tenured faculty in the Department of Chemistry and NanoScience Technology Center at University of Central Florida, Orlando, Florida. During her academic career, Dr. Huo has authored and co-authored more than 80 peer-reviewed articles in the field of chemistry and nanotechnology. She is the inventor of the D2Dx™ technology.

Dr. Huo’s research has been supported by multi-million dollars of research funding from the National Science Foundation (NSF), Florida Department of Health, State of Florida, and other private organizations. She was a recipient of the NSF CAREER award, Nanoscale Interdisciplinary Research Team (NIRT) award, and the Scholar Boost award from the State of Florida New Florida 2010 program.